Conditions: Gastric Adenocarcinoma; Esophageal Squamous Cell Carcinoma; Nasopharyngeal Carcinoma; Head and Neck Squamous Cell Carcinoma
Interventions: Biological: 3 mg/kg humanized anti-PD-1 mAb; Biological: 10 mg/kg humanized anti-PD-1 mAb
Sponsor: Shanghai Junshi Bioscience Co.,Ltd.
Not yet recruiting - verified September 2016
http://ift.tt/2dAA0KM
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
http://bit.ly/2SylJiJ
-
Duraisamy Balaguru, Matthew Rodriguez, Stephanie Leon, Louis K Wagner, Charles W Beasley, Andrew Sultzer, Mohammed T Numan Annals of P...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου